Nom du produit:tert-butyl 2,6-dichloropyridine-3-carboxylate
IUPAC Name:tert-butyl 2,6-dichloropyridine-3-carboxylate
- CAS：1013647-75-0
- Formule moléculaire：C10H11Cl2NO2
- Pureté：95%+
- Numéro de catalogue：CM330041
- Poids moléculaire：248.11
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1013647-75-0
- Formule moléculaire:C10H11Cl2NO2
- Point de fusion:-
- Code SMILES:O=C(C1=CC=C(Cl)N=C1Cl)OC(C)(C)C
- Densité:
- Numéro de catalogue:CM330041
- Poids moléculaire:248.11
- Point d'ébullition:
- N° Mdl:MFCD26396106
- Stockage:
Category Infos
- Pyridines
- Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
- Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
- Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
- Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.
Column Infos
- Vanzacaftor
- Vertex Pharmaceuticals announced that Health Canada has accepted for review its New Drug Submission (NDS) for vanzacaftor/tezacaftor/deutivacaftor, a once-daily triple combination therapy for people living with cystic fibrosis (CF) ages 6 years and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Vanzacaftor is a small molecule cystic fibrosis transmembrane conductance regulator (CFTR). Vanzacaftor is also undergoing regulatory review in multiple other jurisdictions, including by the Food and Drug Administration (FDA) in the U.S. and by the European Medicines Agency (EMA) in the E.U.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.
Recherche 
+86 21 5895 0110 
